Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer

Update Il y a 4 ans
Reference: NCT00530621

Woman and Man

Extract

The purpose of this study is to determine if the combination of enzastaurin and pemetrexed can extend survival time without progression of disease for patients who have advanced or metastatic non-small cell lung cancer.


Inclusion criteria

  • non-small cell lung cancer


Links